ROARABLE
FREE $100K
My Trading Account β†’
β–Ύ
Trading Profile Active
Active Trader
Verified Trader
⚑ My $100K Trading Account β†’ β˜… My Saved Watchlist β†’
🟒 My $100K Account β†’ Today Screener Big Ideas Track Record πŸ’° $100K Arena 🎲 Predictions πŸ›οΈ Insiders 8 Analysts
Stock Ratings / Technology / EMR / financials
GEV (46) OTIS (65) GE (56) FXHO (27) ⌘ Pro Terminal β†’

Emerson Electric Company (EMR) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$166.39 +0.26% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $166.15

Emerson Electric Company (EMR) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ β€’ HOLD / WATCH Cap $92.57B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on EMR Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is EMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Emerson Electric Company (NYSE: EMR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $166.39 (+0.26% 1D, market cap $92.57B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 11/20. Across 715 tracked Technology issuers, EMR ranks #113 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does EMR compare to GEV and OTIS in the Technology sector?
β–Ό

Within the Technology sector (Consumer Electronics/Appliances), EMR carries a Roarable C+ (67/100 RQD), trailing P/E of 41.5x, gross margin of 52.8%, and ROIC of 9.7%. By comparison, GEV (GE Vernova Inc.) holds a D grade (46/100 RQD, P/E 48.1x, ROIC 4.4%, cap $228.22B) and OTIS (Otis Worldwide Corporation) posts a C grade (65/100 RQD, P/E 20.5x, ROIC 74.2%, cap $29.84B). Among the 5-stock peer group, OTIS leads on earnings multiple (20.5x) while OTIS leads on capital efficiency (74.2% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for EMR?
β–Ό

Per EMR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0000032604), Emerson Electric Company generated $18.02B in revenue (+3.0% YoY), $2.29B in net income, and $2.67B in free cash flow against $41.94B in total assets and $7.58B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
🎯 EMR TRADE EXECUTION LEVELS + TODAY'S TOP 3 TRADES EXACT ENTRY β€’ HARD STOP-LOSS (SUP) β€’ TARGET (RES) β€’ WHY

Where to Enter $EMR, Where to Set Your Hard Stop-Loss & Today's Top 3 High-Conviction Trades

πŸ† RECENT ALERT WINNERS: $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
CURRENT TICKER SETUP β€’ $EMR R/R 2.9 : 1 β€’ RQD 67/100 (C+)
$EMR
Spot $166.39
1. GET IN (ENTRY)
$165.39–$167.22
2. HARD STOP (SUP)
$158.90 (-4.5%)
3. GET OUT (T1/T2)
$179.37 / $188.35
STOP-LOSS FLOOR (SUP $158.90): Hard stop sits 4.5% below spot to cap downside below key institutional support. If $EMR closes a daily candle below $158.90, step aside.
PROFIT TARGETS (RES $179.37 / $188.35): Scale out 50% at T1 (+7.8%) and trail stop to breakeven for T2 (+13.2%).
Want this $EMR sheet + Today's Top 3 Trades emailed free? Paper Trade $EMR β†’
⚑ TODAY'S TOP 3 SUGGESTED TRADES OF THE DAY (100% FREE CHEAT SHEET) Trade #1 Unlocked β€’ Enter Email Below to Unblur #2 & #3 + Get $EMR Sheet
#1 β€’ $MU R/R 3.2 : 1
Micron Technology, Inc.
IN
$108.50
STOP
$103.90
OUT
$117.50
#2 β€’ πŸ”’ LOCKED R/R 3.4 : 1
AI Liquid-Cooling Leader
Target: +8.53% to +14.86% | Stop: -3.89%
#3 β€’ πŸ”’ LOCKED R/R 3.1 : 1
Cash-Flow Buyback Machine
Target: +8.38% to +14.53% | Stop: -3.93%
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $166.16 (-0.14%)🧬 Cannibal Buyback (-0.96% YoY Shares)βš™οΈ Cash Engine: 12/20 (C-) β€’ 14.8% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 67/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.6% avg 90D alpha vs SPY β€’ 56.4% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERHOLD / WATCH β€’ C+
025507510067
Quant Analyst Panel Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw C Β· Rk B-
Cash (12)Whales (16)SEC (18)Macro (10)CEO (11)
Each axis scored 0–20
12M PRICE TARGET CONE+4.1% Base Target
$204 Bull$173 Base$135 Bear
πŸ“¬ FREE EMR RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for EMR)Realized 20D OHLCV Swing Band: Β±5.6%
Deterministic 5-Pillar Attribution (67/100 Composite)
πŸ” WHY EMR SCORES 67/100 (C+) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (27% of score)

Altman Z-Score 4.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 7/9

β–² #2 Bullish Driver: Whale & Options Positioning+16/20 pts (24% of score)

20D Institutional Volume Accumulation (Β±5.6% realized swing band)

β–Ό #1 Drag / Risk Factor: Macro Regime Fit10/20 pts (-10 pt drag)

Macro rate sensitivity & RSI-14 (54.8) create a -10 pt regime headwind

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
59
Grade C$162.15-1.1% Next Q
Q2 (-2Q)
62
Grade C+$160.29+6.5% Next Q
Q3 (-1Q)
64
Grade C+$170.74-2.5% Next Q
Current
67
Grade C+$166.39+1.6% Hist 90D Ξ±
Trajectory: C (59) β†’ C+ (67)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the EMR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 67/100 (C+) score, EMR faces multiple-compression risk if 41.5x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Priced at 42x earningsβ€”high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($157.95) or 200D SMA ($147.43) invalidates the momentum regime and cuts Target Base ($173.13) toward Bear Floor ($135.04).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $EMRβ€’ $4.8M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œEMR Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
YES 67%NO 33%Trade / Inspect Odds β†’
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL β€’ FY 2025 (10-K)

How EMR Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$2.67B (14.8% FCF Margin)
Revenue$18.02BGross Profit $9.52B (52.8%)Cost of Sales $8.50BOp Profit $2.71B (15%)OpEx (R&D/SG&A) $6.81BNet Profit$2.29B (12.7%)Tax/Other $412.7M

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

β–  Revenueβ–  Net Profitβ–  Free Cash Flow
FY23
Rev $15.16B
FY24
Rev $17.49B
FY25
Rev $18.02B
Fiscal YearRevenueGross MarginOp MarginNet ProfitFree Cash FlowROIC %
FY 2025$18.02B52.8%15%$2.29B$2.67B9.2%
FY 2024$17.49B50.8%13.3%$1.97B$2.91B8.2%
FY 2023$15.16B52.8%102.9%$13.22B-$45.4M38.9%
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring EMR)

  • βœ“Walkthrough of EMR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
EMR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +20.24%β–² ASCENDING CHANNEL
2026-11-04O $164.9H $166.4L $164.9C $166.4VOL 3.07M
RES: $171.7SUP: $153.5🎯 Entry / Stop & Top 3 Trades ↑SMA50: $158.0SMA200: $147.4
$174.3$161.8$149.3$136.8$124.2RES $171.7SUP $153.5$166.42026-05-052026-06-222026-08-062026-09-222026-11-04
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

EMR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ EMR Butterfly Map β†’ + Track EMR β†’
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
31.4%/yr Implied 5Y Growth

vs. +3.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on EMR today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for EMR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EMR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EMR)

Technology Rank #113 of 715 βš”οΈ GEV vs EMR Full Matrix β†’

1. Head-to-Head Technology Peer Comparison (EMR vs. GEV, OTIS, GE, FXHO)

Industry: Consumer Electronics/Appliances (22 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, Emerson Electric Company (EMR) ranks #113 by composite RQD confidence (67/100, grade C+) and #46 by equity capitalization ($92.57B). Within this direct 5-issuer industry benchmark cohort, OTIS leads on earnings valuation at 20.5x trailing P/E, while OTIS leads on capital efficiency and profitability with 74.2% ROIC and β€” gross margin. EMR currently leads its immediate peer cohort in composite quantitative strength at 67/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
EMR ACTIVE
Emerson Electric Company
C+ 67/100 41.5x 52.8% 9.7% +0.26% $92.57B Benchmark Subject
GEV
GE Vernova Inc.
D 46/100 48.1x 19.8% 4.4% +6.49% $228.22B /gev-vs-emr β†’
OTIS
Otis Worldwide Corporation
C 65/100 20.5x β€” 74.2% -1.98% $29.84B /otis-vs-emr β†’
GE
GE Aerospace
D+ 56/100 37.2x β€” 16.8% +1.55% $326.31B /ge-vs-emr β†’
FXHO
UTime Limited (Class A)
E 27/100 β€” 1.0% β€” +0.72% $157.2M /fxho-vs-emr β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-09-30 β€’ CIK 0000032604 β†—

In its most recent audited fiscal period (FY2025, filed 2025-09-30), Emerson Electric Company (EMR) reported GAAP revenue of $18.02B (+3.0% vs. FY2024 revenue of $17.49B , and +18.8% cumulative change since FY2023) , GAAP net income of $2.29B, operating cash flow of $3.10B, and free cash flow of $2.67B (-8.4% YoY). On the balance sheet, EMR closed FY2025 with $41.94B in total assets against $7.58B in total debt (Altman Z-Score: 4.80, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-09-30 $18.02B $2.29B $3.10B $2.67B $41.94B $7.58B
FY2024 (FY) 2024-09-30 $17.49B $1.97B $3.33B $2.91B $42.61B $6.56B
FY2023 (FY) 2023-09-30 $15.16B $13.22B $637.0M -$45.4M $52.38B $12.26B

3. EMR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is EMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Emerson Electric Company (NYSE: EMR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $166.39 (+0.26% 1D, market cap $92.57B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 11/20. Across 715 tracked Technology issuers, EMR ranks #113 in composite RQD confidence.

How does EMR compare to GEV and OTIS in the Technology sector?

Within the Technology sector (Consumer Electronics/Appliances), EMR carries a Roarable C+ (67/100 RQD), trailing P/E of 41.5x, gross margin of 52.8%, and ROIC of 9.7%. By comparison, GEV (GE Vernova Inc.) holds a D grade (46/100 RQD, P/E 48.1x, ROIC 4.4%, cap $228.22B) and OTIS (Otis Worldwide Corporation) posts a C grade (65/100 RQD, P/E 20.5x, ROIC 74.2%, cap $29.84B). Among the 5-stock peer group, OTIS leads on earnings multiple (20.5x) while OTIS leads on capital efficiency (74.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for EMR?

Per EMR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0000032604), Emerson Electric Company generated $18.02B in revenue (+3.0% YoY), $2.29B in net income, and $2.67B in free cash flow against $41.94B in total assets and $7.58B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

Where is EMR trading relative to its 50-day, 200-day, and 52-week technical levels?

EMR last traded at $166.39 (+0.26% on volume of 3,655,155 shares), positioning the stock +5.34% above its 50-day simple moving average ($157.95) and +12.86% above its 200-day simple moving average ($147.43). Across its 52-week range of $122.64 to $171.25, EMR sits at the 90.0% percentile with a 14-day RSI of 54.8 (NEUTRAL RANGE) and an implied next-earnings move of Β±5.6% ($157.07 to $175.71).

Direct Sub-Reports: EMR RQD Cockpit EMR 12M Forecast EMR Earnings & Move EMR Dividends & DRIP EMR Insiders & 13F EMR Whale Options EMR Profit Sankey EMR News & Why
ROARABLE RATING BRIEF β€’ RQD 67/100 (C+) βœ“ SEC XBRL & RQD VERIFIED

EMR β€” Emerson Electric Company: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-09-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Emerson Electric Company (EMR) earns a live Roarable RQD composite score of 67/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $166.39 (+0.26% 1D, market capitalization $92.57B).

  • Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of 9.7%, gross margin of 52.8%, operating margin of 15.5%, and free cash flow yield of 2.80%.
  • Whale 13F & Options Flow (16/20) + Insider Conviction (11/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (10/20) + Forensic Balance Sheet (18/20): Incorporates a 1.34x equity beta, Altman Z-Score of 4.80, Piotroski F-Score of 7/9, and Debt/Equity of 0.37x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Is a NYSE-listed issuer in the Technology sector, operating in the Consumer Electronics/Appliances industry, with a market capitalization of $95.2B. Per the market data, the company reports a gross margin of 52.8%, an operating margin of 15.5%, and a net margin of 12.7%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-09-30), Emerson Electric Company (EMR) reported $18.02B in annual revenue (up from $17.49B in FY2024, +3.0% YoY) and $2.29B in GAAP net income. Over the multi-year SEC filing window from FY2023 ($15.16B revenue, $13.22B net income) through FY2025, EMR scaled operating cash flow to $3.10B and free cash flow to $2.67B, backed by $41.94B in total assets against $7.58B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case (C+ β€’ RQD 67/100): Big institutional funds and options desks are actively positioning on the bullish side. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 16/20, sustained execution supports upside toward the upper end of the $122.64 – $171.25 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 41.5x trailing P/E and 30.9x EV/EBITDA against 15.5% operating margins and a 1.34x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Consumer Electronics/Appliances (Technology), EMR carries a macro regime beta of 1.34 and gross margin of 52.8%.

  • Key Question #1: Can EMR sustain or expand its 15.5% operating margin and 9.7% ROIC against Consumer Electronics/Appliances peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $18.02B and free cash flow of $2.67B, how will capital allocation balance growth reinvestment against $7.58B in total debt?
  • Key Question #3: How sensitive is EMR's 38.6x forward P/E multiple to Technology capital spending cycles and macro interest-rate shifts (Beta 1.34x)?

EMR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Emerson Electric Company (EMR) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to EMR Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

EMR Bull vs. Bear Conversation Board β€” What's Your Call at $166.39?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON EMR 🐻 33% BEARISH CONVICTION
1. Pick Your Side on EMR:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue RQD DEBATE OPENER β€’ Fundamental Long-Only πŸ‚ BULLISH 🎯 Target: $212.77 (+29.0%)
πŸ“Œ Pinned Debate

Institutional whale flow (18/20) and a strong forensic balance sheet (Altman Z 4.8, Piotroski F 7/9) support the rating.

The street is overcomplicating Emerson Electric Company (EMR). Institutional whale flow (18/20) and a strong forensic balance sheet (Altman Z 4.8, Piotroski F 7/9) support the rating.. With an RQD score of 67/100 (C+) and Forensic Balance Sheet at 18/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $178.14.

ArenaChamp_24 πŸ‚ BULL

@MidwestValue Agree on the RQD 67/100 quality, though with 1.34 beta I'm scaling in with half-size at $164.94 and keeping dry powder in case we test $153.39.

FO ForensicBear RQD DEBATE OPENER β€’ 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $138.55 (-16.0%)
Spot @ $164.94

Elevated valuation (P/E TTM 41.5, EV/EBITDA 30.9) against a 2.8% FCF yield and Beta of 1.34 limits the upside case.

Sitting on the sidelines or leaning short EMR above $164.94. Elevated valuation (P/E TTM 41.5, EV/EBITDA 30.9) against a 2.8% FCF yield and Beta of 1.34 limits the upside case.. Until Fundamental Cash Engine (12/20) and FCF yield (2.8%) inflect higher, upside is capped near $171.25.

LIVE TAPE